[{"id":"a3cf5f39-ca91-443d-bfa1-cb90cf87ae2d","acronym":"","url":"https://clinicaltrials.gov/study/NCT00542958","created_at":"2021-01-18T01:58:26.683Z","updated_at":"2024-07-02T16:36:54.219Z","phase":"Phase 1","brief_title":"Study of NK012 in Patients With Refractory Solid Tumors","source_id_and_acronym":"NCT00542958","lead_sponsor":"Nippon Kayaku Co., Ltd.","biomarkers":" UGT1A1","pipe":" | ","alterations":" UGT1A1*28 • UGT1A1*1*1","tags":["UGT1A1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e UGT1A1*28 • UGT1A1*1*1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NK012"],"overall_status":"Completed","enrollment":" Enrollment 39","initiation":"Initiation: 03/01/2007","start_date":" 03/01/2007","primary_txt":" Primary completion: 04/01/2008","primary_completion_date":" 04/01/2008","study_txt":" Completion: 12/01/2011","study_completion_date":" 12/01/2011","last_update_posted":"2019-10-28"}]